President Tinubu Approves Appointment Of NAFDAC Boss, Others

0
Advertisement

Announces Strategic Leadership Changes in Key Health Institutions

In a significant move to elevate the standards of public health administration in Nigeria, has given his approval for the appointment and reappointment of key figures within the Federal Ministry of Health and Social Welfare.

The announcement, made by Presidential spokesperson Ajuri Ngelale on Thursday, reflects President Tinubu’s commitment to ushering in world-class standards for Nigerian public health. The changes in leadership aim to deliver affordable and quality healthcare to all Nigerians, aligning with international best practices.

Advertisement

President Tinubu emphasized that these leadership adjustments are vital to ensuring effective governance and regulatory frameworks in the healthcare sector. Below is the comprehensive list of appointments and reappointments endorsed by President Tinubu:

Read also:FG Drops Treason Charge Against Omoyele Sowore

1. National Agency for Food and Drugs Administration and Control (NAFDAC):
– Board Chairperson: Dr. Mansur Kabir
– Chief Executive Officer: Prof. Moji Adeyeye

Advertisement

2. National Blood Service Commission (NBSC):
– Board Chairperson: Prof. Abba Zubairu
– Chief Executive Officer: Dr. Saleh Yuguda

3. Pharmacy Council of Nigeria (PCN):
– Board Chairperson: Pharm. Wasilat Giwa
– Chief Executive Officer: Pharm. Ibrahim Ahmed

4. Medical Laboratory Science Council of Nigeria (MLSCN):
– Board Chairperson: Dr. Babajide Salako
– Chief Executive Officer: Dr. Tosan Erhabor

5. Moddibo Adama University Teaching Hospital, Yola (MAUTH):
– Chief Medical Director/CEO: Prof. Adamu G. Bakari

These appointments and reappointments underscore President Tinubu’s vision for a healthcare system that not only meets the needs of the Nigerian population but also adheres to global healthcare standards.

Advertisement

The new leadership is expected to steer the mentioned institutions towards achieving excellence in healthcare delivery and regulatory practices.

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here